Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Proteoglycans synthesized by human polymorphonuclear leucocytes in vitro.

P M Bartold1, D G Harkin, L P Bignold

  • 1Department of Pathology, University of Adelaide, Australia.

Immunology and Cell Biology
|February 1, 1989
PubMed
Summary

Human polymorphonuclear leucocytes (PMN) can synthesize and secrete proteoglycans in vitro. These novel proteoglycans are smaller and have a different glycosaminoglycan composition than those from mesenchymal cells.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

The Therapeutic Use of Dental Mesenchymal Stem Cells in Human Clinical Trials.

Journal of dental research·2024
Same author

The ADJ in 2019 - is it relevant?

Australian dental journal·2019
Same author

Potential of iPSC-Derived Mesenchymal Stromal Cells for Treating Periodontal Disease.

Stem cells international·2018
Same author

Periodontitis and Rheumatoid Arthritis: A Review.

Journal of periodontology·2018
Same author

Gingival tissue, an extrasynovial source of malondialdehyde-acetaldehyde adducts, citrullinated and carbamylated proteins.

Journal of periodontal research·2017
Same author

The effect of triclosan on posttranslational modification of proteins through citrullination and carbamylation.

Clinical oral investigations·2017

Area of Science:

  • Biochemistry
  • Cell Biology
  • Immunology

Background:

  • Polymorphonuclear leucocytes (PMN) are key immune cells.
  • The extracellular matrix composition and synthesis by immune cells are not fully understood.

Purpose of the Study:

  • To investigate the in vitro synthesis and secretion of proteoglycans by human PMN.
  • To characterize the biochemical properties of PMN-derived proteoglycans.

Main Methods:

  • Human peripheral blood PMN were isolated and cultured for 24 hours with (35S)-sulfate.
  • Radiolabeled macromolecules were analyzed using enzymatic degradation (papain, chondroitinase, nitrous acid) and size exclusion chromatography (Sepharose CL-4B).
  • Glycosaminoglycan composition and molecular weight were determined.

Related Experiment Videos

Main Results:

  • Significant amounts of 35S-labeled proteoglycans were detected in both PMN cell cultures and the culture medium.
  • Platelet-only cultures did not yield detectable labeled macromolecules, confirming PMN as the source.
  • PMN proteoglycans were characterized as small in size (Kav 0.63) and composed primarily of chondroitin sulfate, with heparan and dermatan sulfate also present.
  • The average molecular weight of the glycosaminoglycans was 16,000 Da.

Conclusions:

  • Human PMN possess the capability to synthesize and secrete proteoglycans in vitro.
  • PMN-derived proteoglycans exhibit distinct characteristics, including smaller molecular size and a unique glycosaminoglycan profile, compared to those synthesized by mesenchymal cells.
  • This finding contributes to understanding the role of PMN in tissue remodeling and extracellular matrix dynamics.